Skip to content

Clinical trials

Terminated Phase 1/2 Lymphoma, Large-Cell, Anaplastic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 1/2 Status: Terminated Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20133
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Autolus Limited1
Bristol-Myers Squibb1
City of Hope Medical Center1
Columbia University1
Jennifer Amengual1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic8
Lymphoma, Large B-Cell, Diffuse6
Burkitt Lymphoma5
Hodgkin Disease5
Lymphoma, Non-Hodgkin5
Immunoblastic Lymphadenopathy4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4
Lymphoma, Mantle-Cell4

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.